Table 3. Cox regression analysis of clinical events in the validation cohort.
| Univariable | Multivariable | |||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| MACE | 1.66 (1.37-2.02) | <0.001 | 1.47 (1.20-1.80) | <0.001 |
| Cardiac death | 2.63 (1.63-4.24) | <0.001 | 2.31 (1.42-3.77) | <0.001 |
| Hospitalisation for heart failure | 1.97 (1.51-2.57) | <0.001 | 1.68 (1.28-2.20) | <0.001 |
| Target lesion revascularisation | 1.07 (0.73-1.57) | 0.739 | 0.89 (0.59-1.32) | 0.553 |
| Repeat myocardial infarction | 1.15 (0.75-1.76) | 0.514 | 0.98 (0.62-1.55) | 0.926 |
| All-cause death | 2.10 (1.39-3.17) | <0.001 | 1.82 (1.18-2.80) | 0.007 |
| CI: confidence interval; HR: hazard ratio; MACE: major adverse cardiovascular events | ||||